Related Experiment Video
Updated: Jun 11, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
Published on: January 9, 2018
[Neuropsychiatric lupus and autoantibodies against ionotropic glutamate receptor (NMDAR)]
1Center for Autoimmune and Musculoskeletal Disorders, The Feinstein Institute for Medical Research NS-LIJ, 350, Community Drive, Manhasset, NY 11030, USA. jcohenso@nshs.edu
Abstract:
Almost half of lupus patients will experience neuropsychiatric symptoms during the course of their disease. The etiology of the neuronal damages is still uncertain and probably multiple. Autoantibodies reactive with brain have been postulated to play a role. The observation of pathogenic autoantibodies binding the NR2A and NR2B subunits of the ionotropic glutamate receptor (NMDAR) illustrates this hypothesis. First studies showed that 40% of lupus patients possess serum titers of anti-NR2A/B antibody, but the presence of these autoantibodies is not always associated with the occurrence of neuronal damages or neuropsychiatric symptoms. Nevertheless, their presence is observed in the cerebrospinal fluid (CSF) of one half of the patients suffering from neurolupus. The presence in the serum of these autoantibodies anti-NR2A/B of the NMDAR is preliminary to their presence in the CSF where their deleterious effect is observable. Their entry into the brain is dependent on a breach of the blood brain barrier (BBB). In conclusion, the serum titer of autoantibodies against NR2A/B subunits is an indication of the potential for neuropsychiatric manifestations during the course of the disease.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Encephalitis ll: Pathophysiology
Antiepileptic Drugs: Glutamate Antagonists
Myasthenia Gravis ll: Pathophysiology
Encephalitis l: Introduction
Multiple Sclerosis l: Introduction
Ligand-Gated Ion Channel Receptor: Gating Mechanism